Roivant Sciences Ltd.
Symbol: ROIV
NASDAQ
11.25
USDTrhová cena dnes
2.0826
Pomer P/E
0.0316
Pomer PEG
9.07B
MRK Cap
- 0.00%
Výnos DIV
Roivant Sciences Ltd. (ROIV) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1692.1 | 2074 | 2055 | |||||
balance-sheet.row.short-term-investments | 0 | 15.3 | 13.6 | 0 | |||||
balance-sheet.row.net-receivables | 0 | 32.7 | 6.7 | 13.8 | |||||
balance-sheet.row.inventory | 0 | 2.8 | -16.5 | 63.9 | |||||
balance-sheet.row.other-current-assets | 0 | 121.8 | 82.2 | 54.3 | |||||
balance-sheet.row.total-current-assets | 0 | 1798.6 | 2146.5 | 2187 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 92.3 | 86.9 | 77 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.long-term-investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.other-non-current-assets | 0 | 49.5 | 25.8 | 36.1 | |||||
balance-sheet.row.total-non-current-assets | 0 | 591 | 438.6 | 402.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.account-payables | 0 | 37.8 | 34.6 | 20.6 | |||||
balance-sheet.row.short-term-debt | 0 | 52.4 | 11.4 | 12.3 | |||||
balance-sheet.row.tax-payables | 0 | 0.5 | 0.7 | 0.2 | |||||
balance-sheet.row.long-term-debt-total | 0 | 429 | 272.5 | 232.7 | |||||
Deferred Revenue Non Current | 0 | 0 | 13.7 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 15.1 | 128.2 | 180.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 509.6 | 339.3 | 308.7 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 22.5 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 65.2 | 73.9 | 74.7 | |||||
balance-sheet.row.total-liab | 0 | 782 | 546.2 | 527.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | 0 | -3772.8 | -2763.7 | -1918.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.6 | -0.9 | 1.4 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 5383 | 4803.6 | 3714.8 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 1607.6 | 2038.9 | 1797.8 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.minority-interest | 0 | 449.8 | 404.5 | 264.2 | |||||
balance-sheet.row.total-equity | 0 | 2057.4 | 2443.4 | 2062 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.total-debt | 0 | 481.4 | 283.9 | 245 | |||||
balance-sheet.row.net-debt | 0 | -1195.4 | -1776.5 | -1810.1 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1115.5 | -924.1 | -900.2 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 18.9 | 5.9 | 0 | |||||
cash-flows.row.deferred-income-tax | 0 | -4.4 | -5.9 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 217.8 | 565 | 85 | |||||
cash-flows.row.change-in-working-capital | 0 | 6.3 | 15.7 | 71.9 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 4.4 | 15.4 | 3.8 | |||||
cash-flows.row.other-working-capital | 0 | 2 | 0.3 | 68.2 | |||||
cash-flows.row.other-non-cash-items | 0 | 33.4 | -334.3 | 191.2 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.acquisitions-net | 0 | 107.9 | 0 | 0 | |||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -28.3 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 320.2 | 0 | |||||
cash-flows.row.other-investing-activites | 0 | -139.4 | 0.6 | 2.4 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -44.3 | 303.3 | -31.7 | |||||
cash-flows.row.debt-repayment | 0 | -30.1 | -21.6 | 0 | |||||
cash-flows.row.common-stock-issued | 0 | 379.7 | 313.4 | 455.8 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0.3 | 0 | -0.1 | |||||
cash-flows.row.dividends-paid | 0 | -162.7 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | 312.3 | 15 | 0.6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 499.5 | 306.8 | 456.3 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 6.3 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | -381.9 | -67.6 | -127.6 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 1692.1 | 2074 | 2141.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2074 | 2141.7 | 2269.3 | |||||
cash-flows.row.operating-cash-flow | 0 | -843.4 | -677.7 | -552.1 | |||||
cash-flows.row.capital-expenditure | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.free-cash-flow | 0 | -856.1 | -695.2 | -557.9 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 61.3 | 55.3 | 23.8 | |||||
income-statement-row.row.cost-of-revenue | 0 | 13.1 | 9 | 2.1 | |||||
income-statement-row.row.gross-profit | 0 | 48.2 | 46.3 | 21.7 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.operating-expenses | 0 | 1125.7 | 1258.1 | 496.5 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1138.8 | 1267 | 498.6 | |||||
income-statement-row.row.interest-income | 0 | 32.2 | 0.4 | 1.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.total-operating-expenses | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | -30 | -288.1 | 560.4 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | -1077.6 | -1211.7 | -1070.9 | |||||
income-statement-row.row.income-before-tax | 0 | -1224.8 | -923.7 | -898.5 | |||||
income-statement-row.row.income-tax-expense | 0 | 5.2 | 0.4 | 1.7 | |||||
income-statement-row.row.net-income | 0 | -1230 | -924.1 | -900.2 |
Často kladené otázky
Čo je Roivant Sciences Ltd. (ROIV) celkové aktíva?
Roivant Sciences Ltd. (ROIV) celkové aktíva sú 2389604000.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.876.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je -1.047.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 35.091.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 39.165.
Aká je Roivant Sciences Ltd. (ROIV) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je -1230024000.000.
Aký je celkový dlh firmy?
Celkový dlh je 481404000.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 1125721000.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.